Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/132764
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pomares, Helena | - |
dc.contributor.author | Palmeri, Claudia Mariela | - |
dc.contributor.author | Iglesias i Serret, Daniel | - |
dc.contributor.author | Moncunill Massaguer, Cristina | - |
dc.contributor.author | Saura-Esteller, José | - |
dc.contributor.author | Núñez-Vázquez, Sonia | - |
dc.contributor.author | Gamundi, Enric | - |
dc.contributor.author | Arnan, Montserrat | - |
dc.contributor.author | Preciado Gallego, Sara | - |
dc.contributor.author | Albericio Palomera, Fernando | - |
dc.contributor.author | Lavilla Grífols, Rodolfo | - |
dc.contributor.author | Pons i Irazazábal, Gabriel | - |
dc.contributor.author | González Barca, Eva | - |
dc.contributor.author | Cosialls Castel, Ana Mª | - |
dc.contributor.author | Gil i Santano, Joan | - |
dc.date.accessioned | 2019-05-07T14:08:59Z | - |
dc.date.available | 2019-05-07T14:08:59Z | - |
dc.date.issued | 2016-02-10 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | http://hdl.handle.net/2445/132764 | - |
dc.description.abstract | Fluorizoline is a new synthetic molecule that induces apoptosis by selectively targeting prohibitins (PHBs). In this study, the pro-apoptotic effect of fluorizoline was assessed in two cell lines and 21 primary samples from patients with debut of acute myeloid leukemia (AML). Fluorizoline induced apoptosis in AML cells at concentrations in the low micromolar range. All primary samples were sensitive to fluorizoline irrespectively of patients' clinical or genetic features. In addition, fluorizoline inhibited the clonogenic capacity and induced differentiation of AML cells. Fluorizoline increased the mRNA and protein levels of the pro-apoptotic BCL-2 family member NOXA both in cell lines and primary samples analyzed. These results suggest that targeting PHBs could be a new therapeutic strategy for AML | - |
dc.format.extent | 14 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Impact Journals | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.11333 | - |
dc.relation.ispartof | Oncotarget, 2016, vol. 7, num. 40, p. 64987-65000 | - |
dc.relation.uri | https://doi.org/10.18632/oncotarget.11333 | - |
dc.rights | cc-by (c) Pomares, Helena et al., 2016 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) | - |
dc.subject.classification | Càncer | - |
dc.subject.classification | Leucèmia | - |
dc.subject.classification | Farmacologia | - |
dc.subject.classification | RNA | - |
dc.subject.classification | Tumors | - |
dc.subject.other | Cancer | - |
dc.subject.other | Leukemia | - |
dc.subject.other | Pharmacology | - |
dc.subject.other | RNA | - |
dc.subject.other | Tumors | - |
dc.title | Targeting prohibitins induces apoptosis in acute myeloid leukemia cells | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 663888 | - |
dc.date.updated | 2019-05-07T14:08:59Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 27542247 | - |
Appears in Collections: | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
663888.pdf | 6.86 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License